Itbor 200mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent indicated for the treatment of various systemic and superficial fungal infections. Itraconazole exerts its antifungal effect by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is essential for the conversion of lanosterol to ergosterol, a critical component of fungal cell membranes. Disruption of ergosterol synthesis results in increased membrane permeability and ultimately fungal cell death. Itbor 200mg is commonly prescribed for infections such as aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis, including oropharyngeal and esophageal candidiasis. The capsule formulation ensures adequate bioavailability when administered orally, with absorption enhanced by acidic gastric conditions. Dosage regimens vary depending on the type and severity of infection, and treatment duration may extend from several weeks to months. It is important to monitor liver function periodically due to potential hepatotoxicity. Caution is advised in patients with congestive heart failure or hepatic impairment. Drug interactions may occur due to itraconazole’s inhibition of cytochrome P450 enzymes, necessitating careful review of concomitant medications. Itbor 200mg Capsule should be used under medical supervision to ensure efficacy and safety.

Dosage & How to Use